These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 20527968)

  • 21. Papain-like protease (PLpro) inhibitory effects of cinnamic amides from Tribulus terrestris fruits.
    Song YH; Kim DW; Curtis-Long MJ; Yuk HJ; Wang Y; Zhuang N; Lee KH; Jeon KS; Park KH
    Biol Pharm Bull; 2014; 37(6):1021-8. PubMed ID: 24882413
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structure-guided design of potent and permeable inhibitors of MERS coronavirus 3CL protease that utilize a piperidine moiety as a novel design element.
    Galasiti Kankanamalage AC; Kim Y; Damalanka VC; Rathnayake AD; Fehr AR; Mehzabeen N; Battaile KP; Lovell S; Lushington GH; Perlman S; Chang KO; Groutas WC
    Eur J Med Chem; 2018 Apr; 150():334-346. PubMed ID: 29544147
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Thiopurine analogues inhibit papain-like protease of severe acute respiratory syndrome coronavirus.
    Chou CY; Chien CH; Han YS; Prebanda MT; Hsieh HP; Turk B; Chang GG; Chen X
    Biochem Pharmacol; 2008 Apr; 75(8):1601-9. PubMed ID: 18313035
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Peptide aldehyde inhibitors challenge the substrate specificity of the SARS-coronavirus main protease.
    Zhu L; George S; Schmidt MF; Al-Gharabli SI; Rademann J; Hilgenfeld R
    Antiviral Res; 2011 Nov; 92(2):204-12. PubMed ID: 21854807
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Feline coronavirus drug inhibits the main protease of SARS-CoV-2 and blocks virus replication.
    Vuong W; Khan MB; Fischer C; Arutyunova E; Lamer T; Shields J; Saffran HA; McKay RT; van Belkum MJ; Joyce MA; Young HS; Tyrrell DL; Vederas JC; Lemieux MJ
    Nat Commun; 2020 Aug; 11(1):4282. PubMed ID: 32855413
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Specific plant terpenoids and lignoids possess potent antiviral activities against severe acute respiratory syndrome coronavirus.
    Wen CC; Kuo YH; Jan JT; Liang PH; Wang SY; Liu HG; Lee CK; Chang ST; Kuo CJ; Lee SS; Hou CC; Hsiao PW; Chien SC; Shyur LF; Yang NS
    J Med Chem; 2007 Aug; 50(17):4087-95. PubMed ID: 17663539
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quaternary structure, substrate selectivity and inhibitor design for SARS 3C-like proteinase.
    Lai L; Han X; Chen H; Wei P; Huang C; Liu S; Fan K; Zhou L; Liu Z; Pei J; Liu Y
    Curr Pharm Des; 2006; 12(35):4555-64. PubMed ID: 17168761
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of homology modeling of the severe acute respiratory syndrome (SARS) coronavirus main protease for structure based drug design.
    Takeda-Shitaka M; Nojima H; Takaya D; Kanou K; Iwadate M; Umeyama H
    Chem Pharm Bull (Tokyo); 2004 May; 52(5):643-5. PubMed ID: 15133227
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structural Basis for the Ubiquitin-Linkage Specificity and deISGylating activity of SARS-CoV papain-like protease.
    Ratia K; Kilianski A; Baez-Santos YM; Baker SC; Mesecar A
    PLoS Pathog; 2014 May; 10(5):e1004113. PubMed ID: 24854014
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Geranylated flavonoids displaying SARS-CoV papain-like protease inhibition from the fruits of Paulownia tomentosa.
    Cho JK; Curtis-Long MJ; Lee KH; Kim DW; Ryu HW; Yuk HJ; Park KH
    Bioorg Med Chem; 2013 Jun; 21(11):3051-7. PubMed ID: 23623680
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structural and functional characterization of MERS coronavirus papain-like protease.
    Lin MH; Chuang SJ; Chen CC; Cheng SC; Cheng KW; Lin CH; Sun CY; Chou CY
    J Biomed Sci; 2014 Jun; 21(1):54. PubMed ID: 24898546
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Isatin compounds as noncovalent SARS coronavirus 3C-like protease inhibitors.
    Zhou L; Liu Y; Zhang W; Wei P; Huang C; Pei J; Yuan Y; Lai L
    J Med Chem; 2006 Jun; 49(12):3440-3. PubMed ID: 16759084
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of novel small-molecule inhibitors of severe acute respiratory syndrome-associated coronavirus by chemical genetics.
    Kao RY; Tsui WH; Lee TS; Tanner JA; Watt RM; Huang JD; Hu L; Chen G; Chen Z; Zhang L; He T; Chan KH; Tse H; To AP; Ng LW; Wong BC; Tsoi HW; Yang D; Ho DD; Yuen KY
    Chem Biol; 2004 Sep; 11(9):1293-9. PubMed ID: 15380189
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Design and Evaluation of Anti-SARS-Coronavirus Agents Based on Molecular Interactions with the Viral Protease.
    Akaji K; Konno H
    Molecules; 2020 Aug; 25(17):. PubMed ID: 32867349
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High-throughput screening identifies inhibitors of the SARS coronavirus main proteinase.
    Blanchard JE; Elowe NH; Huitema C; Fortin PD; Cechetto JD; Eltis LD; Brown ED
    Chem Biol; 2004 Oct; 11(10):1445-53. PubMed ID: 15489171
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of metal-conjugated compounds as inhibitors of 3CL protease of SARS-CoV.
    Hsu JT; Kuo CJ; Hsieh HP; Wang YC; Huang KK; Lin CP; Huang PF; Chen X; Liang PH
    FEBS Lett; 2004 Sep; 574(1-3):116-20. PubMed ID: 15358550
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Boceprevir, GC-376, and calpain inhibitors II, XII inhibit SARS-CoV-2 viral replication by targeting the viral main protease.
    Ma C; Sacco MD; Hurst B; Townsend JA; Hu Y; Szeto T; Zhang X; Tarbet B; Marty MT; Chen Y; Wang J
    Cell Res; 2020 Aug; 30(8):678-692. PubMed ID: 32541865
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Discovery of a novel family of SARS-CoV protease inhibitors by virtual screening and 3D-QSAR studies.
    Tsai KC; Chen SY; Liang PH; Lu IL; Mahindroo N; Hsieh HP; Chao YS; Liu L; Liu D; Lien W; Lin TH; Wu SY
    J Med Chem; 2006 Jun; 49(12):3485-95. PubMed ID: 16759091
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Structure-Based Optimization of ML300-Derived, Noncovalent Inhibitors Targeting the Severe Acute Respiratory Syndrome Coronavirus 3CL Protease (SARS-CoV-2 3CL
    Han SH; Goins CM; Arya T; Shin WJ; Maw J; Hooper A; Sonawane DP; Porter MR; Bannister BE; Crouch RD; Lindsey AA; Lakatos G; Martinez SR; Alvarado J; Akers WS; Wang NS; Jung JU; Macdonald JD; Stauffer SR
    J Med Chem; 2022 Feb; 65(4):2880-2904. PubMed ID: 34347470
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Structural basis of mercury- and zinc-conjugated complexes as SARS-CoV 3C-like protease inhibitors.
    Lee CC; Kuo CJ; Hsu MF; Liang PH; Fang JM; Shie JJ; Wang AH
    FEBS Lett; 2007 Nov; 581(28):5454-8. PubMed ID: 17981158
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.